Skip to main content
Nature Communications logoLink to Nature Communications
. 2024 Aug 12;15:6890. doi: 10.1038/s41467-024-51289-7

Publisher Correction: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial

Mary M McDermott 1,2,, Christopher R Martens 3, Kathryn J Domanchuk 1, Dongxue Zhang 1, Clara B Peek 1,4, Michael H Criqui 5, Luigi Ferrucci 6, Philip Greenland 1,2, Jack M Guralnik 7, Karen J Ho 8, Melina R Kibbe 9, Kate Kosmac 10, Donald Lloyd-Jones 1,2, Charlotte A Peterson 11, Robert Sufit 12, Lu Tian 13, Stephanie Wohlgemuth 14, Lihui Zhao 2, Pei Zhu 1,4, Christiaan Leeuwenburgh 14
PMCID: PMC11319328  PMID: 39134546

Correction to: Nature Communications 10.1038/s41467-024-49092-5, published online 13 June 2024

The abstract for this article was inadvertently truncated after the text ‘…A larger clinical trial to confirm these findings is needed.’; the following text was missing ‘Clinical Trials.gov registration: NCT03743636’. The original article has been updated.


Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES